These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17996586)

  • 1. The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.
    Mitsiades CS; McMillin DW; Klippel S; Hideshima T; Chauhan D; Richardson PG; Munshi NC; Anderson KC
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1007-34, vii-viii. PubMed ID: 17996586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
    Mitsiades CS; Mitsiades NS; Richardson PG; Munshi NC; Anderson KC
    J Cell Biochem; 2007 Jul; 101(4):950-68. PubMed ID: 17546631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions.
    Mitsiades CS; Mitsiades NS; Munshi NC; Richardson PG; Anderson KC
    Eur J Cancer; 2006 Jul; 42(11):1564-73. PubMed ID: 16765041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The malignant clone and the bone-marrow environment.
    Podar K; Richardson PG; Hideshima T; Chauhan D; Anderson KC
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):597-612. PubMed ID: 18070708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutual interaction between myeloma cells and bone marrow microenvironment].
    Abe M
    Rinsho Ketsueki; 2009 Jun; 50(6):453-60. PubMed ID: 19571504
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel biological therapies for the treatment of multiple myeloma.
    Richardson PG; Mitsiades CS; Hideshima T; Anderson KC
    Best Pract Res Clin Haematol; 2005; 18(4):619-34. PubMed ID: 16026741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma.
    Podar K; Richardson PG; Chauhan D; Anderson KC
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):551-66. PubMed ID: 17428175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment.
    Huston A; Leleu X; Jia X; Moreau AS; Ngo HT; Runnels J; Anderson J; Alsayed Y; Roccaro A; Vallet S; Hatjiharissi E; Tai YT; Sportelli P; Munshi N; Richardson P; Hideshima T; Roodman DG; Anderson KC; Ghobrial IM
    Clin Cancer Res; 2008 Feb; 14(3):865-74. PubMed ID: 18245550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microenvironment and molecular biology of the multiple myeloma tumor.
    Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K
    Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of the therapies targeting the interaction of myeloma cells with its bone marrow microenvironment].
    Abe M
    Rinsho Ketsueki; 2013 Jun; 54(6):522-32. PubMed ID: 23823090
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells.
    Roorda BD; ter Elst A; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):187-98. PubMed ID: 18675551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
    Ribatti D; Nico B; Vacca A
    Oncogene; 2006 Jul; 25(31):4257-66. PubMed ID: 16518413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dickkopf-1: a suitable target for the management of myeloma bone disease.
    Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E
    Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively lower expressions of CD54 on primary myeloma cells and their different localizations in bone marrow.
    Iqbal MS; Otsuyama K; Shamsasenjan K; Asaoku H; Mahmoud MS; Gondo T; Kawano MM
    Eur J Haematol; 2009 Oct; 83(4):302-12. PubMed ID: 19500134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma bone marrow niche.
    Basak GW; Srivastava AS; Malhotra R; Carrier E
    Curr Pharm Biotechnol; 2009 Apr; 10(3):345-6. PubMed ID: 19355944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implication of bone marrow microenvironment in pathogenesis of multiple myeloma].
    Fišerová B; Kubiczková L; Sevčíková S; Hájek R
    Klin Onkol; 2012; 25(4):234-40. PubMed ID: 22920162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms for formation of myeloma bone disease].
    Yata K; Abe M; Matsumoto T
    Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the bone marrow microenvironment in multiple myeloma.
    De Raeve HR; Vanderkerken K
    Histol Histopathol; 2005 Oct; 20(4):1227-50. PubMed ID: 16136504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.